Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cystic fibrosis
Pharma
Vertex sets lofty $500M revenue goal for new products in '26
The company expects $500 million in 2026 from new products outside of its flagship CF franchise. Last year, the new drug total was $175.6 million.
Zoey Becker
Feb 13, 2026 12:02pm
CF buyers club aims to grow access to Vertex's Trikafta
Oct 24, 2025 11:17am
Vertex's international sales slide with IP 'violation' in Russia
May 6, 2025 2:23pm
Vertex wins FDA nod for once-daily cystic fibrosis triplet
Dec 23, 2024 10:58am
Vertex lifts sales guidance as Casgevy launch picks up
Aug 2, 2024 11:34am
Vertex inks long-term access deal for CF meds in England
Jun 21, 2024 11:31am
